[HTML][HTML] Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research

JM Giesinger, FLC Loth, NK Aaronson… - Journal of clinical …, 2020 - Elsevier
Objective The objective of this study was to establish thresholds for clinical importance
(TCIs) for the five functioning and nine symptom scales of the European Organisation for …

Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma

I Fraterman, ILM Reijers, P Dimitriadis, A Broeks… - Nature Medicine, 2023 - nature.com
Neoadjuvant immune checkpoint blockade (ICB) outperforms adjuvant ICB for treatment of
stage IIIB–D melanoma, but potential biomarkers of response, such as interferon-gamma …

[HTML][HTML] Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer …

JZ Musoro, C Coens, MAG Sprangers… - European Journal of …, 2023 - Elsevier
Introduction Early guidelines for minimally important differences (MIDs) for the EORTC QLQ-
C30 proposed≥ 10 points change as clinically meaningful for all scales. Increasing …

Framework to leverage physical therapists for the assessment and treatment of chemotherapy-induced peripheral neurotoxicity (CIPN)

S Stoller, S Capozza, P Alberti, M Lustberg… - Supportive Care in …, 2023 - Springer
Purpose Chemotherapy-induced peripheral neurotoxicity (CIPN) is a highly prevalent, dose-
limiting, costly, and tough-to-treat adverse effect of several chemotherapy agents, presenting …

Health-related quality of life following total thyroidectomy and lobectomy for differentiated thyroid carcinoma: a systematic review

V Landry, E Siciliani, M Henry, RJ Payne - Current Oncology, 2022 - mdpi.com
Health-related quality of life (HrQoL) is a major concern for patients with differentiated
thyroid carcinoma (DTC). We aimed to systematically review the literature comparing HrQol …

Impact of breast cancer treatment on employment: results of a multicenter prospective cohort study (CANTO)

A Dumas, I Vaz Luis, T Bovagnet… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Adverse effects of breast cancer treatment can negatively affect survivors' work
ability. Previous reports lacked detailed clinical data or health-related patient-reported …

Safety and patient-reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab versus bevacizumab plus chemotherapy in non–small-cell …

M Reck, T Wehler, F Orlandi, N Nogami… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Atezolizumab, bevacizumab, carboplatin, and paclitaxel (ABCP) demonstrated
survival benefit versus bevacizumab, carboplatin, and paclitaxel (BCP) in chemotherapy …

Patient-reported outcomes following treatment of localised prostate cancer and their association with regret about treatment choices

MA van Stam, NK Aaronson, JLHR Bosch… - European urology …, 2020 - Elsevier
Background Well-documented reports of patients' experiences with different treatments are
important for helping localised prostate cancer (LPC) patients choose among the available …

Screening and assessment of cancer-related fatigue: a clinical practice guideline for health care providers

MI Fisher, JC Cohn, SE Harrington, JQ Lee… - Physical …, 2022 - academic.oup.com
Cancer-related fatigue (CRF) is the most common side effect of cancer treatment. Regular
surveillance is recommended, but few clinical practice guidelines transparently assess study …

Time after ostomy surgery and type of treatment are associated with quality of life changes in colorectal cancer patients with colostomy

KA Silva, AX Duarte, AR Cruz, LB de Araujo… - PLoS One, 2020 - journals.plos.org
Purpose Quality of life in colorectal cancer patients may be affected by colostomy and
treatment, but relevant studies are still scarce and contradictory. The present study aimed to …